HYPERA S A/S (OTCMKTS:HYPMY) Stock Price Up 3%

HYPERA S A/S (OTCMKTS:HYPMY)’s share price rose 3% during trading on Tuesday . The company traded as high as $9.00 and last traded at $9.00, approximately 14,690 shares traded hands during mid-day trading. An increase of 2% from the average daily volume of 14,346 shares. The stock had previously closed at $8.74.

Separately, ValuEngine upgraded HYPERA S A/S from a “sell” rating to a “hold” rating in a research note on Friday, November 15th.

The business has a 50 day simple moving average of $8.38 and a 200 day simple moving average of $8.11. The company has a market capitalization of $5.77 billion, a PE ratio of 20.75 and a beta of 0.72.

About HYPERA S A/S (OTCMKTS:HYPMY)

Hypera SA operates as a pharmaceutical company in Brazil. The company offers prescription medications under the Farmasa, Neo Química, and Luper brands; and over-the-counter medications comprising laxative, antacid, antispasmodic, topical antiseptic, topical, nasal decongestant, and other drugs under Gelol, Anapyon, Biotônico Fontoura, Epocler, Merthiolate, Tamarine, and Rinosoro brands.

See Also: How to build a Fibonacci channel

Receive News & Ratings for HYPERA S A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HYPERA S A/S and related companies with MarketBeat.com's FREE daily email newsletter.